What are the industry standards and guidelines for PVC/PVDC blister pharmaceutical packaging?

Jun 09, 2023 Leave a message

   

      What are the industry standards and guidelines for PVC/PVDC blister pharmaceutical packaging?

        

     PVC/PVDC blister pharmaceutical packaging is one of the common forms of packaging used in the pharmaceutical industry. In order to ensure the quality, safety and consistency of pharmaceutical products, relevant industry standards and guidelines are widely adopted and followed. This article describes the major industry standards and guidelines related to PVC/PVDC blister pharmaceutical packaging.

 

     "PVC/PVDC Packaging": The United States Pharmacopeia (USP) is the authoritative standard for the U.S. pharmaceutical industry, and its Chapter provides guidelines related to PVC/PVDC packaging. The chapter covers the physical and chemical properties of PVC/PVDC materials, packaging acceptability criteria, methods of use, and quality control requirements.

 

Pharma packing pvcpe laminated film

 

     ISO 15798: "Packaging materials and containers - Rigid plastic containers for pharmaceutical packaging materials": International Organization for Standardization (International Organization for Standardization (ISO) developed the ISO 15798 standard specifically for rigid plastic containers in the pharmaceutical industry, which includes PVC/PVDC blister pharmaceutical packaging. The standard details the physical and chemical properties of packaging materials, material selection and quality requirements, package size and marking, closure properties and other key elements.

 

     FDA Guidance: "Pharmaceutical Blister Packaging Materials": The U.S. Food and Drug Administration (FDA) has issued a series of guidelines covering the requirements for pharmaceutical blister packaging materials. These guidelines cover the use of PVC/PVDC materials, safety assessment, chemical compatibility testing, closure performance and stability. Pharmaceutical companies should follow FDA's guidelines to ensure compliance when developing and using PVC/PVDC blister packages.

 

     EP Chapter : "Blister Packages": The European Pharmacopoeia (EP) is the authoritative standard for the European pharmaceutical industry, and its chapter  is dedicated to blister packaging. This chapter describes in detail the physical characteristics of blister packages, the selection and specification of materials, the size and closure properties of the package, and the requirements for stability testing.

 

     In addition to the major standards and guidelines mentioned above, there are many national and regional pharmaceutical regulatory agencies, associations and organizations that have issued guidelines and recommendations related to PVC/PVDC blister pharmaceutical packaging. Pharmaceutical companies should pay close attention to and follow the relevant standards and guidelines applicable to their region to ensure that blister pharmaceutical packaging meets quality and regulatory requirements.

 

     Industry standards and guidelines for PVC/PVDC blister pharmaceutical packaging provide a set of guidelines to help pharmaceutical companies ensure the quality, safety and compliance of their packaging materials. Adherence to these standards and guidelines helps protect the stability of pharmaceuticals and provides safe and reliable medicines for patients.

 

 

     Blister packaging with PVC/PVDC has many advantages and some disadvantages in the pharmaceutical industry. The following is an overview of these aspects.

 

    Advantages:

 

     Excellent barrier properties: PVC/PVDC materials excel in terms of moisture, oxidation and light resistance. These materials are effective in blocking out external moisture, oxygen and light, protecting the stability and quality of pharmaceuticals. The excellent properties of barrier performance help extend the shelf life of pharmaceuticals.

 

    Transparency and visibility: PVC/PVDC films have excellent transparency, making the drug clearly visible in blister packs. Transparency allows for quick and accurate identification of the drug, especially when it is labeled with important information such as dosage instructions, lot numbers and expiration dates. The ability to visually inspect the drug without opening the blister pack improves patient safety and convenience.

 

     Material malleability: PVC/PVDC film can be easily thermoformed into blister cavities of various shapes and sizes to accommodate different sizes and dosages of medications. the malleability and adaptability of PVC/PVDC material makes it well suited for a variety of different pharmaceutical applications.

 

     Cost-effective: PVC/PVDC blister packs are cost effective compared to other packaging options. The relative affordability of these materials makes them an economical choice for pharmaceutical manufacturers. the efficient processing and production methods of PVC/PVDC blister packs also help reduce costs and are therefore favored by both generic and branded drug manufacturers.

 

cristal-pvdc-rigid

 

     Disadvantages:

 

     Environmental impact: The production and handling of PVC materials can have a negative impact on the environment. These materials may release harmful substances during the manufacturing process, and there are difficulties in recycling and disposal of PVC. Although PVDC is relatively unlikely to have these problems, its production process still has some impact on the environment.

 

      Health risks: Some chemical components in PVC/PVDC materials may cause health problems. For example, plasticizers and additives that may be contained in PVC may release harmful substances. Although in pharmaceutical blister packaging, these materials are usually in direct contact with the drug for a short period of time, the health risks need to be a concern for certain sensitive people or for long-term use of the drug.

 

      In summary, the use of PVC/PVDC for blister packaging offers many advantages in the pharmaceutical industry, including excellent barrier properties, transparency and visibility, material malleability, and cost effectiveness. However, they also have a number of disadvantages, including environmental impact and health risks. Pharmaceutical companies should consider these factors when selecting suitable blister packaging materials and ensure compliance with relevant regulations and standards to ensure the quality and safety of pharmaceutical products.

 

 

Send Inquiry

whatsapp

skype

VK

Inquiry